news.cmlviz.com
menu
share

Stock Volatility Risk Alert: Alexion Pharmaceuticals Inc Price Volatility Hits An Unsually High Level




Alexion Pharmaceuticals Inc (NASDAQ:ALXN) Price Volatility Hits An Unsually High Level

Date Published:

Stock Risk Alert
Before we cover the full analysis we make a quick alert here that Alexion Pharmaceuticals Inc (NASDAQ:ALXN) has seen its stock price whip around at an escalated level. We'll go through the details below -- but that's the lede -- the stock has been moving and the market's reaction is like a yellow post it note on the face of the ticker that reads "this is not equilibrium" with an HV20 of 39.8% verus the HV20 of the S&P 500 at 8.45%.



Another bit to this risk alert, which we cover in the article, is that while the historical volatility may be an escalated level (the stock has been whipping around), the real question that needs to be answered for option traders is not if the HV20 is high, but rather if the implied volatility that is priced for the next 30-days accuratley reflects what we're about to see in the stock for the next month.

To jump forward and examine if owning or shorting options has been a positive trade in Alexion Pharmaceuticals Inc, you can go here: Getting serious about option trading.

PREFACE
This is a proprietary realized volatility rating created by Capital Market Laboratories (CMLviz) based on a large number of data interactions for Alexion Pharmaceuticals Inc (NASDAQ:ALXN) . We examine the little used gem of daily stock volatility over a 20-day and 30-day trading period, as well as comparisons to the last year and the actual stock returns over the last three- and six-months and the S&P 500 and Nasdaq 100 indices.


Option trading isn't about luck -- this four minute video will change your trading life forever: Option Trading and Truth

As a heads up, in the "Why This Matters" section at the end of this article on Alexion Pharmaceuticals Inc (NASDAQ:ALXN) , we're going to take a step back and show really clearly that there is actually a lot less "luck" in successful option trading than most people are aware of. This idea of an "option trading expert" is vastly over complicated so those with the information advantage can continue to profit at the expense of the rest.

But before that, let's turn back to ALXN. Here are the exact steps that led us to this rating, and whether it's a risk alert or a holding pattern.

ALXN Recent Price Volatility


Rating
Price volatility using proprietary measures has hit an escalated level.

Note
Even though Alexion Pharmaceuticals Inc generates substantial revenue, its market cap is small enough that just the fact that it's a biotechnology pharmaceutical company, in and of itself, makes ALXN susceptible to excessive risk as the stock may vascillate based on drug trial results, FDA decisions, competitor FDA data, new government pricing rules, and especially takeover rumors. Here is a rolling annual volatility chart of the biotech index (IBB) versus the Nasdaq 100 and the S&P 500. Note how elevated the biotechnology sector volatility is (the pink curve) relative to the S&P 500.



Let's take a deep dive into some institutional level volatility measures for Alexion Pharmaceuticals Inc (NASDAQ:ALXN) .

Alexion Pharmaceuticals Inc Stock Performance
ALXN is down -13.4% over the last three months and down -1.8% over the last six months. The stock has returned -19.0% over the last year. The current stock price is $108.

ALXN Step 1: Stock Returns
The one-year stock return does not impact the volatility rating since we are looking at a shorter time horizon. However, the rating does examine the 3-month returns and the absolute difference between the 3-month and 6-month returns.

  The 3-month stock return of -13.4% has a small impact on the price volatility rating for ALXN.
  The greater than 10% difference between the 3-month and 6-month stock returns has an impact on the price volatility rating for ALXN.

ALXN Step 2: Daily Price Volatility Level
The HV30® takes the stock's day to day historical volatility over the last 30-days and then annualizes it. The HV20 looks back over just 20-days -- a shorter time period. Here is the breakdown for Alexion Pharmaceuticals Inc (NASDAQ:ALXN) and how the day-by-day price historical volatilities have impacted the rating:

  The HV20 of 45.5% is in the middle ground, neither elevated nor depressed, so in this case the raw HV20 number has no impact on ALXN's volatility rating.


ALXN Step 3: Alexion Pharmaceuticals Inc HV20 Compared to Indices
* The HV20 for ALXN is substantially larger than that for both the S&P 500 and the NASDAQ 100 which raises the volatility rating.

* The HV20 for ALXN is substantially larger than that for the Health Care ETF (XLV) which raises the volatility rating.

Here is summary data in tabular and chart format.

           ALXN
           HV20    
   S&P 500
HV20
   NASDAQ 100
HV20   
   XLV
HV20   
           45.5%    8.45%    15.66%    8.14%

ALXN Step 4: Daily Volatility Percentiles and Highs

We also examine the annual high of the HV30 in our rating.
  The 52 week high in HV30 for ALXN is 70.0%, which is high and has an upward impact on the price volatility rating.

Here is summary data in tabular and chart format.

           ALXN
           HV20    
   ALXN
HV30
   ALXN
HV30 High   
           45.5%    39.8%    70.0%

Final Price Volatility Percentile Level: ALXN
The final evolution of the volatility rating for Alexion Pharmaceuticals Inc is a comparison of the HV30 value relative to its past, which is neatly summarized in the percentile -- a scoring mechanism that goes from a low of 1 to a high of 100.

Alexion Pharmaceuticals Inc Realized Volatility Percentiles